Literature DB >> 5961434

The relative toxicites of methotrexate and aminopterin.

D G Johns, A T Iannotti, A C Sartorelli, J R Bertino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1966        PMID： 5961434     DOI： 10.1016/0006-2952(66)90022-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate model.

Authors:  Meredith K Chuk; Diane E Cole; Cynthia McCully; Natalia A Loktionova; Anthony E Pegg; Robert J Parker; Gary Pauly; Brigitte C Widemann; Frank M Balis; Elizabeth Fox
Journal:  Cancer Chemother Pharmacol       Date:  2010-08-20       Impact factor: 3.333

2.  Renal and hepatic toxicity after high-dose 7-hydroxymethotrexate in the rat.

Authors:  E Smeland; R M Bremnes; A Andersen; R Jaeger; T J Eide; N E Huseby; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Pharmacokinetics of methotrexate (MTX) and 7-hydroxymethotrexate (7-OH-MTX) in rats and evidence for the metabolism of MTX to 7-OH-MTX.

Authors:  L Fahrig; H Brasch; H Iven
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

4.  Inhibition of 7-hydroxymethotrexate formation by amsacrine.

Authors:  R M Bremnes; E Smeland; N P Willassen; E Wist; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  High-dose 7-hydromethotrexate: acute toxicity and lethality in a rat model.

Authors:  E Smeland; O M Fuskevåg; K Nymann; J S Svendesn; R Olsen; S Lindal; R M Bremnes; J Aarbakke
Journal:  Cancer Chemother Pharmacol       Date:  1996       Impact factor: 3.333

6.  Leucovorin rescue allows effective high-dose pralatrexate treatment and an increase in therapeutic index in mesothelioma xenografts.

Authors:  Philip M Tedeschi; Yamini K Kathari; Iqra N Farooqi; Joseph R Bertino
Journal:  Cancer Chemother Pharmacol       Date:  2014-09-09       Impact factor: 3.333
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.